Skip to content

Efficacy analysis of TMS quasi-intelligent stimulation in the treatment of chronic insomnia disorder

Efficacy analysis of TMS quasi-intelligent stimulation in the treatment of chronic insomnia disorder

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043921
Enrollment
Unknown
Registered
2021-03-05
Start date
2021-04-01
Completion date
Unknown
Last updated
2021-07-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia disorder

Interventions

Smart group:Precise Transcranial Magnetic Stimulation Therapy with Ami Robotic Localization
Artificial group:Manually localized TMS therapy

Sponsors

Zhumadian Psychiatric Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) Age between 18 and 65, male or female; (2) Primary school education or above; (3) Patients with chronic insomnia meeting ICSD-3 diagnostic criteria, PSQI > score 7; (4) HAMA < 7 points, HAMD < 7 points; (5) Have not taken any drugs related to sleep treatment for nearly 1 month.

Exclusion criteria

Exclusion criteria: (1) Patients with other mental disorders meeting the diagnostic criteria of ICD-10; (2) Patients with severe impairment of heart, liver, kidney and respiratory function or other serious diseases of various systems, such as epilepsy; (3) Metal implants were implanted in the body, and antidepressants and other psychotropic drugs were used in the past 2 months; (4) Have received or are currently undergoing non-convulsive electroconvulsive therapy or transcranial direct current stimulation or transcranial alternating current stimulation.

Design outcomes

Primary

MeasureTime frame
PSQI;ISI;Proportion of stage 3 sleep;

Countries

china

Contacts

Public Contacthuifang Zhang

Zhumadian Psychiatric Hospital

8732930@qq.com+86 13461818685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026